» Articles » PMID: 36828533

Diagnostic Performance of Dengue NS1 and Antibodies by Serum Concentration Technique

Overview
Date 2023 Feb 24
PMID 36828533
Authors
Affiliations
Soon will be listed here.
Abstract

Dengue infection has been a public health problem worldwide, especially in tropical areas. A lack of sensitive diagnostic methods in the early phase of the illness is one of the challenging problems in clinical practices. We, herein, analyzed 86 sera of acute febrile patients, from both dengue and non-dengue febrile illness, to study the diagnostic performance of dengue diagnostics. When compared with detection by Polymerase Chain Reaction (PCR), dengue NS1 detection by enzyme-linked immunosorbent assay (ELISA) had the highest sensitivity of 82.4% (with 94.3% specificity), while NS1 by rapid diagnostic test (RDT) had 76.5% sensitivity. IgM detection by ELISA and RDT showed only 27.5% and 17.9% sensitivity, respectively. The combination of NS1 and IgM in RDT yielded a sensitivity of 78.4%, with 97.1% specificity. One of the essential steps in making a diagnosis from patient samples is the preparation process. At present, a variety of techniques have been used to increase the number of analytes in clinical samples. In this study, we focused on the sample concentration method. The sera were concentrated three times with the ultrafiltration method using a 10 kDa molecular weight cut-off membrane. The results showed an increase in the sensitivity of RDT-NS1 detection at 80.4%, with 100% specificity. When combining NS1 and IgM detection, the concentration method granted RDT an 82.4% sensitivity, with 100% specificity. In conclusion, serum concentration by the ultrafiltration method is a simple and applicable technique. It could increase the diagnostic performance of point-of-care dengue diagnostics.

Citing Articles

Latin America's Dengue Outbreak Poses a Global Health Threat.

de Almeida M, Merighi D, Visnardi A, Boneto Goncalves C, Amorim V, de Almeida Ferrari A Viruses. 2025; 17(1).

PMID: 39861846 PMC: 11768874. DOI: 10.3390/v17010057.


Clinical and Laboratory Features and Treatment Outcomes of Dengue Fever in Pediatric Cases.

Nusrat N, Chowdhury K, Sinha S, Mehta M, Kumar S, Haque M Cureus. 2024; 16(12):e75840.

PMID: 39698191 PMC: 11654319. DOI: 10.7759/cureus.75840.


Retrospective study on the dengue fever outbreak in Puntland State, Somalia.

Jama S, Abshir S, Jama J, Abdi M BMC Infect Dis. 2024; 24(1):735.

PMID: 39061013 PMC: 11282595. DOI: 10.1186/s12879-024-09552-1.


Etiological characterization of acute undifferentiated febrile illness in Apartadó and Villeta municipalities, Colombia, during COVID-19 pandemic.

Silva-Ramos C, Gil-Mora J, Serna-Rivera C, Martinez Diaz H, Restrepo-Lopez N, Agudelo-Florez P Infez Med. 2023; 31(4):517-532.

PMID: 38075419 PMC: 10705856. DOI: 10.53854/liim-3104-11.


Diagnosis, Characterization and Treatment of Emerging Pathogens.

Chen S Microorganisms. 2023; 11(8).

PMID: 37630592 PMC: 10459198. DOI: 10.3390/microorganisms11082032.

References
1.
Shen W, Galula J, Chang G, Wu H, King C, Chao D . Improving dengue viral antigens detection in dengue patient serum specimens using a low pH glycine buffer treatment. J Microbiol Immunol Infect. 2015; 50(2):167-174. DOI: 10.1016/j.jmii.2015.05.008. View

2.
Vongpunsawad S, Intharasongkroh D, Thongmee T, Poovorawan Y . Seroprevalence of antibodies to dengue and chikungunya viruses in Thailand. PLoS One. 2017; 12(6):e0180560. PMC: 5491253. DOI: 10.1371/journal.pone.0180560. View

3.
Tscheliessnig A, Satzer P, Hammerschmidt N, Schulz H, Helk B, Jungbauer A . Ethanol precipitation for purification of recombinant antibodies. J Biotechnol. 2014; 188:17-28. DOI: 10.1016/j.jbiotec.2014.07.436. View

4.
Nisalak A . LABORATORY DIAGNOSIS OF DENGUE VIRUS INFECTIONS. Southeast Asian J Trop Med Public Health. 2015; 46 Suppl 1:55-76. View

5.
Negida A, Fahim N, Negida Y . Sample Size Calculation Guide - Part 4: How to Calculate the Sample Size for a Diagnostic Test Accuracy Study based on Sensitivity, Specificity, and the Area Under the ROC Curve. Adv J Emerg Med. 2019; 3(3):e33. PMC: 6683590. DOI: 10.22114/ajem.v0i0.158. View